share_log

Ligand Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials

SEC announcement ·  May 22, 2018 17:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more